An increasing number of new medical devices are aiming to help people deal with health conditions in ways that previously required the aid of a medical professional.

GHTC member the PATH Malaria Vaccine Initiative recently named some of the world's most eminent malaria scientists to its Vaccine Science Portfolio Advisory
Council.

In related news, the biotechnology company Antigen Discovery has received a three-year grant worth $2.5 million from the National Institute of Allergy and Infectious Diseases for its efforts to develop a malaria vaccine.